Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Clinical and Molecular Hepatology
>
2019
>
25
>
3
Volume:
25
Issue:
3
1. Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Page:223—233
2. Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
Page:331—332
3. Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
Page:326—330
4. Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
Page:317—325
5. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Page:305—316
6. Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
Page:294—304
7. Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Page:283—293
8. How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Page:280—282
9. Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Page:270—279
10. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Page:264—269
11. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Page:245—263
12. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Page:234—244